Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China To Invest $1 Billion To Ramp Up New Drug Innovation

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - China will invest RMB 6.6 billion ($960 million) to launch a massive new drug development and manufacturing program from 2008 to 2010. Roughly 3,290 projects focused on preclinical studies and identifying new candidates are awaiting approval to initiate in 2009
Advertisement

Related Content

BIO Reaches Out To China, Encourages Harmonization
BIO Reaches Out To China, Encourages Harmonization
China’s Strongest Pharmas Likely To Thrive Through Innovation And Acquisition Despite Global Crisis
Despite Global Crisis, China’s Strongest Pharma Firms Likely To Thrive In 2009 Through Innovation And Acquisitions
Despite Global Crisis, China’s Strongest Pharma Firms Likely To Thrive In 2009 Through Innovation And Acquisitions
China’s Strongest Pharmas Likely To Thrive Through Innovation And Acquisition Despite Global Crisis
U.S. Economic Crisis, Beijing’s Perks, Could Trigger Reverse Brain Drain
U.S. Economic Crisis, Beijing’s Perks, Could Trigger Reverse Brain Drain
China Kicks Off Pharmaceutical Manufacturing And Innovation Project
Advertisement
UsernamePublicRestriction

Register

SC067222

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel